DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Cefazaflur
Cefazaflur
(12) United States Patent (10) Patent No.: US 9,662.400 B2 Smith Et Al
PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
Computational Antibiotics Book
Pharmaceuticals Appendix
Anew Drug Design Strategy in the Liht of Molecular Hybridization Concept
Pharmaceutical Appendix to the Harmonized Tariff Schedule
Pharmaceutical Appendix to the Harmonized Tariff Schedule
WO 2014/159510 Al 2 October 2014 (02.10.2014) P O P C T
Sk&F 59962 (Cefazaflur)
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available
Directed Molecular Evolution of Fourth-Generation Cephalosporin Resistance in Wellington Moore Iowa State University
PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2008) (Rev
PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
Supplemental Material Etable 1. Variable Classification in EHR
In Vitro Susceptibilities of Aeromonas Hydrophila to 32 Antimicrobial Agents ROBERT J
Extended Spectrum Beta-Lactamases
Antibiotics/Antibacterial Drug Use, Their Marketing and Promotion During the Post-Antibiotic Golden Age and Their Role in Emergence of Bacterial Resistance
Top View
(12) Patent Application Publication (10) Pub. No.: US 2015/0150995 A1 Taft, III Et Al
Antibiotic Classes
Stembook 2018.Pdf
Adverse Events in Patients Taking Cephalosporins Versus Placebo for Any Indication
Laboratory Emerging Pathogens Initiative (Epi) Roll up Modifications Technical and User Manual
Antimicrobial Agents and Chemotherapy
6-Veterinary-Medicinal-Products-Criteria-Designation-Antimicrobials-Be-Reserved-Treatment
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Pharmaceutical Appendix to the Tariff Schedule 2
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Antibiotic Resistance Gene Resource and Assay List
Pharmaabkommen A1 E
(12) United States Patent (10) Patent No.: US 9,675,592 B2 Daum Et Al
Approximately 500 Isolates of Bacteria Were Employed. the Organisms Were Obtained As Clinical Isolates from Various Geographical
Customs Tariff - Schedule Xxi - 1
Role of Persistent Environmental
NG198 Evidence Review G
Literature Search Strategy for Treatment of Stable
Pharmaceutical Appendix to the Tariff Schedule 2
NG198 Evidence Review F1
Harmonized Tariff Schedule of the United States (2006) (Rev
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Monitoring Antibiotics in the Environment (FINAL VERSION After Public Proofs)
Customs Tariff - Schedule
Pharmaceutical Appendix to the Tariff Schedule 2
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Supplementary
L:\0900\0900PHARMAPPX .Wpd
(12) Patent Application Publication (10) Pub. No.: US 2017/0071884 A1 Page Et Al
NG198 Evidence Review E2
N I W O 2011/152806
(12) United States Patent (10) Patent No.: US 8,084,445 B2 Huq Et Al